期刊文献+

中山市古镇健康人群水痘-带状疱疹病毒血清抗体阳性率调查 被引量:4

下载PDF
导出
摘要 目的应用膜抗原荧光抗体实验(FAMA)调查中山市古镇正常人群水痘-带状疱疹病毒(VZV)的流行现状,为水痘预防措施的制定提供依据。方法采用以VZV感染的细胞作为抗原、异硫氰酸荧光素(FITC)标记的羊抗人IgG作为二抗的FAMA实验对随机抽取的590份正常人血清进行特异性VZV抗体检测。结果 FAMA实验结果容易判定,并且具有较好敏感性、特异性和重复性。应用此法检测590份血清标本中,VZV抗体总体阳性率为77.12%;1-3岁、4-6岁、7-13岁、14-19岁、20-29岁、30-39岁、40-49岁及〉50岁年龄组血清抗体阳性率分别是17.33%、51.56%、73.91%、91.26%、92.78%、95.65%、98.11%和100%。1-3岁年龄组血清抗体阳性率最低,血清抗体阳性率随年龄的增大而升高。不同性别间阳性率差异无统计学意义(P〉0.005),不同年龄组间阳性率差异有统计学意义(P〈0.001)。结论该研究采用的FAMA法检测人群中VZV抗体敏感性好、特异性高、结果易判定,是VZV抗体检测的可靠方法。VZV感染主要发生在儿童时期,预防水痘感染和流行,应以1-3岁儿童为VZV疫苗免疫的首选对象。3岁以上者宜选择没有水痘史的儿童作为免疫对象。
出处 《齐齐哈尔医学院学报》 2010年第7期1100-1103,共4页 Journal of Qiqihar Medical University
  • 相关文献

参考文献17

  • 1Feldman S,L·Lott.Varicella in children with cancer:impact of antiviral therapy and prophylaxis[J].Pediatrics,1987,80:465-472.
  • 2Enders G,Miller E,Cradock-Watson J,et al.Consequences of varicella and herpes zoster in pregnancy prospective study of 1739 cases[J].Lancet,1994,343:1548-1551.
  • 3Williams V,A·A·Gershon,P·A·Brunell.Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence[J].J.Infect.Dis,1974,130:669-672.
  • 4Gershon A,Chen J,LeRussa P,et al.In Manual of Clinical Microbiology[J].9th Ed.,American Society of Microbiology Press,Washington DC,2007.
  • 5Khoshnood B,Debruyne M,Lancon F,et al.Sero-prevalence of Varicella in the French Population[J].The Pediatric Infectious Disease Journal,2006,25(1):41-44.
  • 6Ool PL,Goh KT,Doralsingham S,et al.Prevalence of varicella-zoster vins infection on Singapore[J].Southeast Asian J Trop Med publ Hlth,1992,23:22-25.
  • 7Lee BW.Review of varicella zoster sero-epidemiology in India and Southeast Asia[J].Trop Med Intern Health,1998,3(11):886-890.
  • 8Salleras L,Dominguez A,Vidal J,et al.Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain).Rationale for universal vaccination programme[J].Vaccine,2000,19:183-188.
  • 9王敏力,沈琦.水痘-带状疱疹免疫球蛋白研究进展[J].中国生物制品学杂志,2007,20(9):701-704. 被引量:11
  • 10Wreghitt TG,Tedder RS,Nagington J,et al.Antibody assays for varicella virus:comparison of competitive enzyme linked immunosorbent assay (ELISA),competitive radioimmunoassay (RIA),complement fixation,and indirect immuno-fluorescence assays[J].J Med Virol,1984,13(4):361-370.

二级参考文献25

  • 1American Academy of Pediatrics.Section 3.Summaries of Infectious Diseases.In:Pickering LK,Baker CJ,Long SS,et al,eds.Red Book:2006 Report of the Committee on Infectious Diseases.27th ed.Elk Grove Village,IL:American Academy of Pediatrics,2006.711-725.
  • 2Hambleton S,Gershon AA.Preventing varicella-zoster disease.Clin Microbio Rev,2005,18(1):70-80.
  • 3Grant RM,Weitzman SS,Sherman CG,et al.Fulminant disseminated varicella zoster virus infection without skin involvement.J Clin Virol,2002,24(1-2):7-12.
  • 4Stratman E.Visceral zoster as the presenting feature of disseminated herpes zoster.J Am Acad Dermatol,2002,46(5):771-774.
  • 5Koren G,Money D,Boucher M,et al.Serum concentrations,efficacy,and safety of a new,intravenously administered varicella zoster immune globulin in pregnant women.J Clin Pharmacol,2002,42(3):267-274.
  • 6Casadevall A,Dadachova E,Pirofski LA.Passive antibody therapy for infectious diseases.Nat Rev Microbiol,2004,2(9):695-703.
  • 7Hugler P,Siebrecht P,Hoffmann K,et al.Prevention of postherpetic neuralgia with varicella-zoster hyperimmune globulin.Eur J Pain,2002,6(6):435-445.
  • 8Centers for Disease Control and Prevention (CDC).Varicella zoster immune globulin for the prevention of chickenpox.MMWR Morb Mortal Wkly Rep,1984,33(7):84-90,95-100.
  • 9Gershon AA,Piomelli S,Karpatkin M,et al.Antibody to varicella-zoster virus after passive immunization against chickenpox.J Clin Microbiol,1978,8(6):733-735.
  • 10Zaia JA,Levin MJ,Wright GG,et al.A practical method for preparation of varicella-zoster immune globulin.J Infec Dis,1978,137(5):601-604.

共引文献10

同被引文献63

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部